AzTrials
AzTrials

HypertensionPeri-op HTNNCT03678207

The Effectiveness of a Preoperative Blood Pressure Screening Program to Identify Undiagnosed Hypertension in Ambulatory Surgery Patients

An observational study of Hypertension and Perioperative Hypertension, run by Hospital for Special Surgery, New York at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

Elevated blood pressure is the largest contributing risk factor to all-cause and cardiovascular mortality. According to the U.S. Preventive Services Task Force, hypertension affects nearly 30% of the adult population. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Hypertension, Perioperative Hypertension
What is being tested?
Anesthesiologist phone call
Type of treatment
Pill or oral medicine
How many people
0 participants
Where
1 siteUnited States
Study dates
20 Jun 2018to 19 Jun 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients receiving elective ambulatory surgery with a preoperative blood pressure measurement greater than 160 (systolic) and/or 90 (diastolic)

Who may be able to join

  • Patients undergoing elective ambulatory surgery
  • Patients with a pre-operative elevated BP defined as greater than 160/90
  • Patients above the age of 18
  • English speaking

Who cannot join

  • Patients with a pre-existing diagnosis of HTN
  • Patients who are taking a hypertensive medication
  • Patients who had a pre-operative surgical screening assessment

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Hospital for Special Surgery

    New York, New York, 10021

Other trials in United States

About this study

Elevated blood pressure is the largest contributing risk factor to all-cause and cardiovascular mortality. According to the U.S. Preventive Services Task Force, hypertension affects nearly 30% of the adult population. Many patients remain undiagnosed, despite the consensus that screening and timely diagnosis is paramount. In this study, 108 ambulatory surgery patients with elevated blood pressure (160/90) that are not yet formally diagnosed with hypertension will be enrolled and alerted of their high blood pressure by a co-investigator MD. They will request permission to follow-up with the patient and the patient's primary care provider 6 months after the initial phone call to check in on the status of their diagnosis and any action taken (lifestyle changes, medication) to alleviate their high blood pressure. Patients will receive a follow-up letter/email at 6 and 3 months to remind them of their potential diagnosis.

Being tested
Anesthesiologist phone call
Medical subject headings
Hypertension

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Anesthesiologist phone callOther

    Patients receiving ambulatory surgery with no prior diagnosis of hypertension but have elevated blood pressure prior to surgery. Patients will receive a phone call from a participating anesthesiologist 1-3 days after surgery notifying them of their high blood pressure and obtaining oral consent to participate in the study. Patients will receive reminders via mail about following up with their PCP.

Study groups in NCT03678207
Study groupRoleWhat they receive
Potential Undiagnosed HTNNot described
Receives: Other: Anesthesiologist phone call

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Diagnosis of hypertension 6 months after surgery

    The number of patients with previously undiagnosed hypertension that have obtained a formal diagnosis of hypertension

    Measured: 6 months postoperative

Secondary outcomes (2)
  1. PCP follow up 6 months after surgery

    Number of patients that followed-up with a primary care physician for further hypertension testing within 6 months of surgery

    Measured: 6 months postoperative

  2. Hypertension treatment 6 months after surgery

    Number of patients that followed-up for their hypertension that received some sort of treatment, either medication or lifestyle

    Measured: 6 months postoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Sep 2018
  2. Study start20 Jun 2018
  3. Primary completion19 Jun 2019
  4. Study completion19 Jun 2019

Why it stopped: The investigator no longer desires to persue the trial. No enrollments were made.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03678207
Sponsor's protocol ID
2018-0914
Acronym
Peri-op HTN
Status last verified
Oct 2019
First submitted
18 Sep 2018
Last updated
12 Feb 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Hypertension and Perioperative Hypertension, run by Hospital for Special Surgery, New York at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 12 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Diagnosis of hypertension 6 months after surgery (time frame: 6 months postoperative). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Feb 2026; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in